PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Wiley-Blackwell

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

High Impact EMBO Molecular Medicine to Publish Under Open Access Model - Wiley-Blackwell and EMBO announced that EMBO Molecular Medicine will, as of March 2012, join the Wiley Open Access publishing program - EMBO.org / Wiley.com
High Impact EMBO Molecular Medicine to Publish Under Open Access Model

 

NewswireToday - /newswire/ - Hoboken, NJ, United States, 2012/03/07 - Wiley-Blackwell and EMBO announced that EMBO Molecular Medicine will, as of March 2012, join the Wiley Open Access publishing program - EMBO.org / Wiley.com. NYSE: JWa, JWb

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Books/Publishing/Newspapers Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc., and EMBO today announced that EMBO Molecular Medicine will, as of March 2012, join the Wiley Open Access publishing program. Articles in the journal will be open access and free to view, download and share for non-commercial use.

Since its launch in 2009, EMBO Molecular Medicine has attracted extremely high quality submissions and attained a first Impact Factor of 8.833, placing it 6th in the Medicine Research and Experimental ISI Category. With its emphasis on translational medicine, the studies published in EMBO Molecular Medicine are of interest to a wide spectrum of researchers, clinicians and the public. Converting to open access allows all readers to benefit from the high-level research advances reported in EMBO Molecular Medicine, aiding the dissemination of biomedical research and accelerating discovery.

EMBO Molecular Medicine was the recipient of the 2009 PROSE Award for Best Journal/ Science, Technology and Medicine.

Dr. Stefanie Dimmeler, Chief Editor of EMBO Molecular Medicine and Director of the Institute of Cardiovascular Regeneration at the Center for Molecular Medicine, Goethe University, Frankfurt, noted,“EMBO Molecular Medicine meets an important need in the scientific community by reporting the very latest advances in clinical science and basic research. Open access publishing of articles in EMBO Molecular Medicine will enhance the visibility of the journal and provide even greater reach for our published articles.”

Dr. Bernd Pulverer, Head of Scientific Publications at EMBO, said,“EMBO Molecular Medicine publishes important scientific discoveries with direct impact on clinical medicine and we are therefore particularly pleased to be in a position to increase access to this cutting edge research. EMBO Molecular Medicine is one of the highest profile biomedical journals to have converted to the Open Access model.”

David Nicholson, Vice President and Journals Publishing Director for Life Sciences at Wiley-Blackwell, commented: “We are delighted to be working with our partners at EMBO on the conversion of EMBO Molecular Medicine to a full open access arrangement. The journal has had a great impact in the community so far, and we are looking forward to building on this success as part of our growing activities in open access publishing.”

The journal is supported by the professional editors Anneke Funk and Céline Carret and an eminent international panel of Senior Editors, Drs. Dario Alessi, Giulio Cossu, Uta Francke, Fred Gage, Matthias Hentze, Edison T. Liu, Philippe Sansonetti and Bart de Strooper.

EMBO Molecular Medicine will publish all future articles under an Attribution-NonCommercial 3.0 Unported (CC BY-NC 3.0) Creative Commons License, which permits use, distribution, reproduction and adaptation in any medium, provided the original work is properly cited and is not used for commercial purposes. A publication fee will be payable by authors or their funder on acceptance of their primary research articles.

Please visit EMBO Molecular Medicine's website for further information.

EMBO Molecular Medicine is published by Wiley-Blackwell on behalf of EMBO.

About Wiley
Founded in 1807, John Wiley & Sons, Inc. (wiley.com) has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace.

Our core businesses publish scientific, technical, medical, and scholarly (STMS) journals, encyclopedias, books, and online products and services; professional/trade books, subscription products, training materials, and online applications and Websites; and educational materials for undergraduate and graduate students and lifelong learners. Wiley's global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company's Website can be accessed at wiley.com. The Company is listed on the New York Stock Exchange under the symbols JWa and JWb.

Wiley-Blackwell is the international STMS publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world’s leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit wileyblackwell.com/ or our online platform, Wiley Online Library (wileyonlinelibrary.com), one of the world’s most extensive multidisciplinary collections of online resources, covering life, health, social and physical sciences, and humanities.

About Wiley Open Access
Wiley Open Access, announced in February 2011, provides authors wishing to publish their research outcomes in an open access journal with a range of new high quality publications which meet the requirements of funding organizations and institutions where these apply. Wiley Open Access journals are supported by a network of high-quality journals and societies as well as internationally-renowned editorial board members.

About EMBO
EMBO (embo.org) stands for excellence in the life sciences. The organization enables the best science by supporting talented researchers, stimulating scientific exchange and advancing policies for a world-class European research environment.

EMBO is an organization of 1500 leading life scientist members that fosters new generations of researchers to produce world-class scientific results. EMBO helps young scientists to advance their research, promote their international reputations and ensure their mobility. Courses, workshops, conferences and scientific journals disseminate the latest research and offer training in cutting-edge techniques to maintain high standards of excellence in research practice. EMBO helps to shape science and research policy by seeking input and feedback from our community and by following closely the trends in science in Europe.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Books/Publishing/Newspapers Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Wiley-Blackwell

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Books/Publishing/Newspapers articles,
CATCH Visitors via Your Competitors Announcements!


High Impact EMBO Molecular Medicine to Publish Under Open Access Model

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Wiley | EMBO
Publisher Contact: Amy Molnar / Ben Norman - Wiley.com 
201-748-8844 / +44(0)12 4377 0375 LifescienceNews[.]wiley.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Wiley-Blackwell securities in any jurisdiction including any other companies listed or named in this release.

Books/Publishing/Newspapers via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Wiley-Blackwell / Company Profile


Read Books/Publishing/Newspapers Most Recent Related Newswires:

Hearst Magazines to Introduce New Magazine Brand with Food Network Sensation Ree Drummond - The Pioneer Woman
Dusk Comics Flagship Comic Takes New Form
Hearst Agrees to Acquire CAMP Systems International, Inc. - A Leading Aviation Software-as-a-Service Company
Wiley Celebrates the 2016 Nobel Prize Laureates
Book Recounts A Year of Backpacking World Travel by An American and An Aussie Lady
Debut Author Joins the Trending, Most Unreliable Narrators List for Young Readers
American Institute of Ultrasound in Medicine Selects Wiley to Publish the Journal of Ultrasound in Medicine
S&P Global Platts to Launch Fujairah Oil Products Price Assessments
Ranku Acquired by Wiley
S&P Global Platts Launches Formal Consultation on Shift to Asia ULSD Benchmarks
Pixel Hall Press Celebrates the 2nd birthday of 'Traveling Left of Center & Other Stories'
Independent Author from Cape Town, Richard Gradner Launches His Second Novel - Unicorn in Cape Town
Wiley Signs Definitive Agreement to Acquire Atypon
American Geophysical Union Partners with Wiley to Take on New Geohealth Initiative
Wiley to Publish Molecular Oncology Bringing together All Four Journals from the Federation of European Biochemical Societies At FEBS Press

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)